XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Net Sales:        
Total net sales $ 7,340,454 $ 6,845,820 $ 13,856,709 $ 13,541,598
Cost of sales:        
Total cost of sales 2,600,303 2,663,210 5,392,755 5,391,267
Gross profit 4,740,151 4,182,610 8,463,954 8,150,331
Operating expenses:        
Research and development 866,198 650,031 1,536,643 1,386,556
Selling, general and administrative 2,446,635 1,724,800 4,708,498 3,531,782
Total operating expenses 3,312,833 2,374,831 6,245,141 4,918,338
Operating income 1,427,318 1,807,779 2,218,813 3,231,993
Interest income 130,951 346 246,843 442
Other income 23,258 11,555 41,455 27,793
Income before income taxes 1,581,527 1,819,680 2,507,111 3,260,228
Income tax expense 310,424 390,110 537,357 697,600
Net income $ 1,271,103 $ 1,429,570 $ 1,969,754 $ 2,562,628
Net income per common share:        
Basic $ 0.07 $ 0.08 $ 0.11 $ 0.15
Diluted $ 0.07 $ 0.08 $ 0.11 $ 0.15
Weighted average shares outstanding:        
Basic 17,352,340 17,253,746 17,334,553 17,250,059
Diluted 17,354,030 17,253,746 17,340,104 17,250,059
Product        
Net Sales:        
Total net sales $ 7,340,454 $ 6,647,617 $ 13,489,810 $ 13,343,395
Cost of sales:        
Total cost of sales $ 2,600,303 2,646,462 5,335,349 5,374,519
Engineering development contracts        
Net Sales:        
Total net sales   198,203 366,899 198,203
Cost of sales:        
Total cost of sales   $ 16,748 $ 57,406 $ 16,748